Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Proxymetacaine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Proxymetacaine 0.5% eye dps 0.5ml ud preservative free
1107000Q0AAABAB
|
Proxymetacaine hydrochloride | Proxymetacaine hydrochloride | Eye | 58 |
|
Minims proxymetacaine 0.5% eye drops 0.5ml unit dose
1107000Q0BCAAAB
|
Minims proxymetacaine hydrochloride | Proxymetacaine hydrochloride | Eye | 13 |
|
Minims proxymetacaine 0.5%/fluoresc 0.25% eye dps 0.5ml ud
1107000Q0BCABAC
|
Minims proxymetacaine hydrochloride | Proxymetacaine hydrochloride | Eye | No data available |
|
Proxymetacaine 0.5%/Fluoresc 0.25% eye dps 0.5ml
1107000Q0AAACAC
|
Proxymetacaine hydrochloride | Proxymetacaine hydrochloride | Eye | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.